Treatment with Immunic Therapeutics‘ experimental oral therapy vidofludimus calcium (IMU-838) lowered the levels of a nerve damage marker…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
About two-thirds of people with relapsing forms of multiple sclerosis (MS) remained completely free from relapses over six years…
Supplements of indole 3-lactate (ILA), a molecule made by gut bacteria, significantly reduced disease severity and promoted myelin repair in…
An association between the proteins IgG1 and CXCL10 in the fluid around the brain may help predict the risk of…
An imaging feature called the T1-dark rim, which is visible on standard MRI scans of people with multiple sclerosis…
Children with multiple sclerosis (MS) who start on high-efficacy therapies experience fewer relapses and reduced MRI disease activity in…
Treatment options for progressive types of multiple sclerosis (MS) have expanded dramatically over the past decade, and several promising…
COMPASS, a digital tool that provides support for managing the daily challenges of living with a long-term health condition such…
Few multiple sclerosis (MS) clinical trials have used a so-called pragmatic design, which evaluates the effectiveness of interventions in…
An international team of scientists has created a computational model that seeks to give a picture of…
In neurological inflammatory conditions like multiple sclerosis (MS), inflammatory immune cells may enter the brain through arachnoid cuff exit…
Scientists at The University of Texas at Austin (UT Austin) have developed a novel non-opioid compound, called FEM-1689, that is…
Scientists have developed a technique to more precisely map the myelin sheath, the fatty covering around nerve fibers that…
Real-world data collected from a registry can be used to reliably compare the effectiveness of different multiple sclerosis (MS)…
People with multiple sclerosis (MS) who received a university-level education are more likely to be on…
People in the early stages of multiple sclerosis (MS) who have more spontaneous myelin repair in the cortex —…
New guidelines from the Spanish Society of Neurology emphasize the importance of early diagnosis and prompt treatment in the management…
In the U.S., pregnant people with multiple sclerosis (MS) who are Black or Hispanic tend to have…
In people with multiple sclerosis (MS) who have previously received a stem cell transplant, a second transplant can…
Problems with the workings of a protein called hnRNP A1 drives nerve death in multiple sclerosis (MS) by affecting…
Genetic changes that predispose people to developing multiple sclerosis (MS) first emerged among herding populations who migrated to Eastern…
People with multiple sclerosis (MS) have high levels of T-cells in their spinal fluid that specifically target cells infected…
In people with multiple sclerosis (MS), disability worsening independent of relapse activity — commonly known as “silent progression” —…
In people with a family history of multiple sclerosis (MS), exclusive breastfeeding in the first months of life may…
An analysis of data covering nearly 200 people with multiple sclerosis (MS) found no association between dairy or gluten…
Throughout 2023, Multiple Sclerosis News Today brought consistent coverage to our readers of the latest scientific research, developments in…
A 20-week talk therapy program led to significant reductions in fatigue for people with multiple sclerosis (MS) — benefits…
Natural killer (NK) cells, a type of immune cell, are critical for preventing an immune response against an infecting virus…
The molecular process that brings vitamin B12 into the brain can also transport Gilenya (fingolimod), an approved treatment for…
A novel compound that can lessen toxic overactivation of nerve cells was found to significantly reduce disease activity and restore…